BiotechTube
Home/Sequana Medical/Karin Van Damme
KV

Karin Van Damme

Chief Financial Officer

Sequana Medical

Therapeutic Areas

Hepatology (Liver Disease)Cardiology (Heart Failure)Oncology

Sequana Medical Pipeline

DrugIndicationPhase
alfapump® SystemRecurrent or Refractory Ascites due to Liver CirrhosisApproved
DSR® TherapyHeart Failure with Fluid OverloadPhase 1/2

Leadership Team at Sequana Medical

IC
Ian Crosbie
Chief Executive Officer
DO
Dr. Oliver Gödje
Chief Medical Officer
PC
Pierre Chauvineau
Chairman of the Board
View full Sequana Medical profile